Author

P. Bhargava

h-index 4 View on Semantic Scholar

We have 3 of 41 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Development of a Consensus-Based Risk Stratification Algorithm for HR+/HER2− Early Breast Cancer to Guide Adjuvant CDK4/6i Therapy: Outcomes from a Multidisciplinary Workshop in India

Purpose Hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2–) early breast cancer (EBC) is treated with curative intent, but risk of recurrence (RoR) remains a challenge. The identification of high RoR EBC patients is inconsistent, highlighting the need for a simplified approach. This...

K. Mallavarapu, Rakesh Reddy B, Somashekhar Sp et al. · Breast Cancer · 0 citations

Open access Sep 2026

Prevalence of claudin 18.2 in gastric cancer patients from India

There is no data from India regarding the prevalence of Claudin 18.2 (CLDN18.2) in patients with gastric adenocarcinomas (GC). Records of treatment-naive, histologically confirmed gastric cancer (GC) diagnosed between January 2018 and October 2023 were retrieved from a prospectively maintained database at th...

Jaspreet Kaur, Gauri Wagh, R. Patil et al. · South Asian Journal of Cance... · 0 citations

Aug 2026

Self-Reported Compliance With Adjuvant Endocrine Therapy in Young Women With Hormone Receptor-Positive Early Breast Cancer: A Real-World Study from a Tertiary Cancer Center in India.

Noncompliance with ET is a clinically significant predictor of inferior outcomes in young women with HR+ EBC, and structured survivorship-focused interventions are essential to improve long-term compliance and survival outcomes.

M. Trikha, Sushmita Rath, Pradeep Ventrapati et al. · Clinical Breast Cancer · 0 citations